Sheiner PA et al. |
Acute renal failure associated with the use of ibuprofen in two liver transplant recipients on FK506. |
1994 |
Transplantation |
pmid:7513099
|
Therapondos G et al. |
Cardiac hypertrophy in liver transplant recipients: tacrolimus, cyclosporine or both? |
2003 |
Transplantation |
pmid:12883220
|
Gaynor JJ and Ciancio G |
The Importance of Using Serially Measured Tacrolimus Clearance Values, Especially During the Early Posttransplantation Period. |
2018 |
Transplantation |
pmid:29271869
|
Ogunseinde BA et al. |
A case of tacrolimus (FK506)-induced pancreatitis and fatality 2 years postcadaveric renal transplant. |
2003 |
Transplantation |
pmid:12883222
|
Keenan RJ et al. |
Immunosuppressive properties of thalidomide. Inhibition of in vitro lymphocyte proliferation alone and in combination with cyclosporine or FK506. |
1991 |
Transplantation |
pmid:1719668
|
Burroughs TE et al. |
Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. |
2007 |
Transplantation |
pmid:17452891
|
Andrades KM et al. |
Modulation of Candida albicans virulence by antirejection immunosuppressant drugs. |
2013 |
Transplantation |
pmid:23380869
|
Adams PS et al. |
Postoperative cardiac tamponade after kidney transplantation: a possible consequence of alemtuzumab-induced cytokine release syndrome. |
2013 |
Transplantation |
pmid:23380870
|
Migita K et al. |
FK506 markedly enhances apoptosis of antigen-stimulated peripheral T cells by down-regulation of Bcl-xL. |
1999 |
Transplantation |
pmid:10532544
|
Leroy-Matheron C et al. |
Inhibitor against coagulation factor V after liver transplantation. |
1999 |
Transplantation |
pmid:10532550
|
Boleslawski E et al. |
Defective inhibition of peripheral CD8+ T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection. |
2004 |
Transplantation |
pmid:15223897
|
Fridell JA et al. |
Steroid withdrawal for pancreas after kidney transplantation in recipients on maintenance prednisone immunosuppression. |
2006 |
Transplantation |
pmid:16906038
|
Hostettler KE et al. |
Cyclosporine A mediates fibroproliferation through epithelial cells. |
2004 |
Transplantation |
pmid:15223908
|
Yang CW et al. |
Preconditioning with cyclosporine A or FK506 differentially regulates mitogen-activated protein kinase expression in rat kidneys with ischemia/reperfusion injury. |
2003 |
Transplantation |
pmid:12544865
|
Lykavieris P et al. |
Angioedema in pediatric liver transplant recipients under tacrolimus immunosuppression. |
2003 |
Transplantation |
pmid:12544888
|
Lawsin L and Light JA |
Severe acute renal failure after exposure to sirolimus-tacrolimus in two living donor kidney recipients. |
2003 |
Transplantation |
pmid:12544890
|
Molano RD et al. |
Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody. |
2003 |
Transplantation |
pmid:12811239
|
Bilolo KK et al. |
Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat. |
2003 |
Transplantation |
pmid:12811249
|
Waldman WJ et al. |
Inhibition of angiogenesis-related endothelial activity by the experimental immunosuppressive agent leflunomide. |
2001 |
Transplantation |
pmid:11707749
|
Morrissey PE et al. |
Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. |
1997 |
Transplantation |
pmid:9089224
|
Murase N et al. |
Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. |
1990 |
Transplantation |
pmid:1696405
|
Kiuchi T et al. |
A hepatic graft tuberculosis transmitted from a living-related donor. |
1997 |
Transplantation |
pmid:9089234
|
Propper DJ et al. |
FK506--its influence on anti-class 1 MHC alloantibody responses to blood transfusions. |
1990 |
Transplantation |
pmid:1696409
|
Jeske HC et al. |
Gemcitabine with cyclosporine or with tacrolimus exerts a synergistic effect and induces tolerance in the rat. |
2003 |
Transplantation |
pmid:14557751
|
Loucaidou M et al. |
Five-year results of kidney transplantation under tacrolimus-based regimes: the persisting significance of vascular rejection. |
2003 |
Transplantation |
pmid:14557763
|
Gerlach UA et al. |
Intragraft and Systemic Immune Parameters Discriminating Between Rejection and Long-Term Graft Function in a Preclinical Model of Intestinal Transplantation. |
2017 |
Transplantation |
pmid:27607529
|
King-Biggs MB et al. |
Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation. |
2003 |
Transplantation |
pmid:12792493
|
Welberry Smith MP et al. |
Alemtuzumab induction in renal transplantation permits safe steroid avoidance with tacrolimus monotherapy: a randomized controlled trial. |
2013 |
Transplantation |
pmid:24056618
|
Barth RN et al. |
Prolonged survival of composite facial allografts in non-human primates associated with posttransplant lymphoproliferative disorder. |
2009 |
Transplantation |
pmid:19996923
|
Ciancio G et al. |
Randomized trial of dual antibody induction therapy with steroid avoidance in renal transplantation. |
2011 |
Transplantation |
pmid:22027927
|
Karlsson H and Nässberger L |
FK506 suppresses the mitogen-induced increase in lymphocyte adhesiveness to endothelial cells, but does not affect endothelial cell activation in response to inflammatory stimuli. |
1997 |
Transplantation |
pmid:9355847
|
Thervet E et al. |
Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients. |
2003 |
Transplantation |
pmid:14578760
|
McDiarmid SV et al. |
A comparison of renal function in cyclosporine- and FK-506-treated patients after primary orthotopic liver transplantation. |
1993 |
Transplantation |
pmid:7692636
|
Tabasco-Minguillan J et al. |
Insulin requirements after liver transplantation and FK-506 immunosuppression. |
1993 |
Transplantation |
pmid:7692637
|
Tanabe M et al. |
Combined immunosuppressive therapy with low dose FK506 and antimetabolites in rat allogeneic heart transplantation. |
1994 |
Transplantation |
pmid:7518619
|
Jain A et al. |
Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation. |
2000 |
Transplantation |
pmid:10972220
|
Wang SC et al. |
A dual mechanism of immunosuppression by FK-506. Differential suppression of IL-4 and IL-10 levels in T helper 2 cells. |
1993 |
Transplantation |
pmid:7692640
|
Prud'homme GJ et al. |
GABA protects human islet cells against the deleterious effects of immunosuppressive drugs and exerts immunoinhibitory effects alone. |
2013 |
Transplantation |
pmid:23851932
|
Hilbrands R et al. |
Predictive factors of allosensitization after immunosuppressant withdrawal in recipients of long-term cultured islet cell grafts. |
2013 |
Transplantation |
pmid:23857001
|
Burroughs TE et al. |
Increasing incidence of new-onset diabetes after transplant among pediatric renal transplant patients. |
2009 |
Transplantation |
pmid:19667939
|
Mittal SK et al. |
Increased interleukin-10 production without expansion of CD4+CD25+ T-regulatory cells in early stable renal transplant patients on calcineurin inhibitors. |
2009 |
Transplantation |
pmid:19667950
|
Coto E and Tavira B |
Pharmacogenetics of calcineurin inhibitors in renal transplantation. |
2009 |
Transplantation |
pmid:19667964
|
Stojanovic J et al. |
Immune Desensitization Allows Pediatric Blood Group Incompatible Kidney Transplantation. |
2017 |
Transplantation |
pmid:27463537
|
Nobori S et al. |
Long-term acceptance of fully allogeneic cardiac grafts by cotransplantation of vascularized thymus in miniature swine. |
2006 |
Transplantation |
pmid:16421473
|
Yu S et al. |
Influence of CYP3A5 gene polymorphisms of donor rather than recipient to tacrolimus individual dose requirement in liver transplantation. |
2006 |
Transplantation |
pmid:16421475
|
Kung L and Halloran PF |
Immunophilins may limit calcineurin inhibition by cyclosporine and tacrolimus at high drug concentrations. |
2000 |
Transplantation |
pmid:10933159
|
Beatty PR et al. |
Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines. |
1998 |
Transplantation |
pmid:9603175
|
Maes BD et al. |
Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporine. |
1999 |
Transplantation |
pmid:10589943
|
Gruber SA et al. |
Initial results of solitary pancreas transplants performed without regard to donor/recipient HLA mismatching. |
2000 |
Transplantation |
pmid:10933170
|
Shapiro R et al. |
Alopecia as a consequence of tacrolimus therapy. |
1998 |
Transplantation |
pmid:9603186
|
Fernandez LA et al. |
The effects of maintenance doses of FK506 versus cyclosporin A on glucose and lipid metabolism after orthotopic liver transplantation. |
1999 |
Transplantation |
pmid:10589951
|
Lang T et al. |
Production of IL-4 and IL-10 does not lead to immune quiescence in vascularized human organ grafts. |
1996 |
Transplantation |
pmid:8824477
|
Mehra MR et al. |
Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression. |
2002 |
Transplantation |
pmid:12490790
|
Batten P et al. |
Human T cell responses to human and porcine endothelial cells are highly sensitive to cyclosporin A and FK506 in vitro. |
1999 |
Transplantation |
pmid:10589954
|
Dickenmann MJ et al. |
Blood eosinophilia in tacrolimus-treated patients: an indicator of Pneumocystis carinii pneumonia. |
1999 |
Transplantation |
pmid:10589963
|
Tokita D et al. |
High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. |
2008 |
Transplantation |
pmid:18301333
|
Gruessner RW and Sharp HL |
Living-related intestinal transplantation: first report of a standardized surgical technique. |
1997 |
Transplantation |
pmid:9415566
|
Guerville F et al. |
Transplantation with pathologic kidneys to improve the pool of donors: an example of shunt nephritis. |
2012 |
Transplantation |
pmid:22487813
|
Mestres J et al. |
Late subcapsular lymphocele in a kidney graft. |
2012 |
Transplantation |
pmid:22487814
|
Swinnen LJ et al. |
Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder. |
2008 |
Transplantation |
pmid:18645482
|
Shapiro R et al. |
Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody. |
2008 |
Transplantation |
pmid:18431232
|
Sureshkumar KK and Chopra B |
In search of an optimal induction agent in kidney transplantation. |
2014 |
Transplantation |
pmid:24978038
|
Porrini E et al. |
Prediabetes in patients receiving tacrolimus in the first year after kidney transplantation: a prospective and multicenter study. |
2008 |
Transplantation |
pmid:18431233
|
Welberry Smith MP and Baker RJ |
The author's reply. |
2014 |
Transplantation |
pmid:24978039
|
Naesens M et al. |
Maturation of dose-corrected tacrolimus predose trough levels in pediatric kidney allograft recipients. |
2008 |
Transplantation |
pmid:18431234
|
Singla AK et al. |
Cerulomycin Caerulomycin [corrected] A: a potent novel immunosuppressive agent. |
2014 |
Transplantation |
pmid:24949498
|
Walsh C et al. |
Anti-CD25 monoclonal antibody replacement therapy for chronic kidney disease in liver transplant recipients. |
2013 |
Transplantation |
pmid:23296149
|
Amundsen R et al. |
Rimonabant affects cyclosporine a, but not tacrolimus pharmacokinetics in renal transplant recipients. |
2009 |
Transplantation |
pmid:19384170
|
de Fijter JW |
Tacrolimus dosing in mycophenolate-treated patients--can we get away with less? |
2011 |
Transplantation |
pmid:21654351
|
Brunet M et al. |
Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil. |
2006 |
Transplantation |
pmid:16495801
|
Kessler L et al. |
Tacrolimus-associated optic neuropathy after pancreatic islet transplantation using a sirolimus/tacrolimus immunosuppressive regimen. |
2006 |
Transplantation |
pmid:16495816
|
Markus PM et al. |
Effects of in vivo treatment with FK506 on natural killer cells in rats. |
1991 |
Transplantation |
pmid:1707562
|
Reyes J et al. |
Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection. |
2000 |
Transplantation |
pmid:10910279
|
Meiser BM |
The best dosing for initial tacrolimus application is trough level adapted! |
2005 |
Transplantation |
pmid:15714162
|
Podesser BK et al. |
Comparison of low and high initial tacrolimus dosing in primary heart transplant recipients: a prospective European multicenter study. |
2005 |
Transplantation |
pmid:15714171
|
Taylor-Fishwick DA et al. |
Evidence that rapamycin has differential effects of IL-4 function. Multiple IL-4 signaling pathways and implications for in vivo use. |
1993 |
Transplantation |
pmid:7689258
|
Tamura K et al. |
Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell. |
1995 |
Transplantation |
pmid:7539960
|
Shaefer MS et al. |
Falsely elevated FK-506 levels caused by sampling through central venous catheters. |
1993 |
Transplantation |
pmid:7689264
|
Yamauchi A et al. |
Neurotoxicity induced by tacrolimus after liver transplantation: relation to genetic polymorphisms of the ABCB1 (MDR1) gene. |
2002 |
Transplantation |
pmid:12352921
|
Valdivia LA et al. |
Dendritic cell replacement in long-surviving liver and cardiac xenografts. |
1993 |
Transplantation |
pmid:7689265
|
Borni-Duval C et al. |
Risk factors for BK virus infection in the era of therapeutic drug monitoring. |
2013 |
Transplantation |
pmid:23778568
|
van Boekel GA et al. |
Effect of mild diarrhea on tacrolimus exposure. |
2012 |
Transplantation |
pmid:22955188
|
Mourer JS et al. |
Late calcineurin inhibitor withdrawal prevents progressive left ventricular diastolic dysfunction in renal transplant recipients. |
2012 |
Transplantation |
pmid:22955227
|
Danziger-Isakov LA et al. |
The risk, prevention, and outcome of cytomegalovirus after pediatric lung transplantation. |
2009 |
Transplantation |
pmid:19461492
|
Guasch A et al. |
Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy. |
2010 |
Transplantation |
pmid:20811320
|
Ciancio G et al. |
A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year. |
2004 |
Transplantation |
pmid:14742990
|
Farley DE et al. |
The effect of two new immunosuppressive agents, FK506 and didemnin B, in murine pregnancy. |
1991 |
Transplantation |
pmid:1713360
|
Arai K et al. |
Limb allografts in rats immunosuppressed with FK506. I. Reversal of rejection and indefinite survival. |
1989 |
Transplantation |
pmid:2479130
|
Azzola A et al. |
Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation. |
2004 |
Transplantation |
pmid:14742993
|
van Hooff JP et al. |
Tacrolimus and posttransplant diabetes mellitus in renal transplantation. |
2005 |
Transplantation |
pmid:15940032
|
Ferdman RM et al. |
Rapid intravenous desensitization to antithymocyte globulin in a patient with aplastic anemia. |
2004 |
Transplantation |
pmid:14743005
|
Wang X et al. |
Immunosuppression with a combination of pg490-88 and a subtherapeutic dose of FK506 in a canine renal allograft model. |
2005 |
Transplantation |
pmid:15940043
|
Nankivell BJ et al. |
Oral cyclosporine but not tacrolimus reduces renal transplant blood flow. |
2004 |
Transplantation |
pmid:15167607
|
Gibson SW et al. |
Nutritional immunomodulation leads to enhanced allograft survival in combination with cyclosporine A and rapamycin, but not FK506. |
2000 |
Transplantation |
pmid:10852592
|
Pirenne J et al. |
Combined transplantation of small and large bowel. FK506 versus cyclosporine A in a porcine model. |
1996 |
Transplantation |
pmid:8685944
|
Cohen JB et al. |
Belatacept Compared With Tacrolimus for Kidney Transplantation: A Propensity Score Matched Cohort Study. |
2017 |
Transplantation |
pmid:27941427
|
Ekberg H et al. |
Relationship of tacrolimus exposure and mycophenolate mofetil dose with renal function after renal transplantation. |
2011 |
Transplantation |
pmid:21562449
|
Kuypers DR et al. |
Clinically relevant drug interaction between voriconazole and tacrolimus in a primary renal allograft recipient. |
2006 |
Transplantation |
pmid:16794545
|
Talento A et al. |
A single administration of LFA-1 antibody confers prolonged allograft survival. |
1993 |
Transplantation |
pmid:7679531
|
Mor E et al. |
Reversal of gastrointestinal toxicity associated with long-term FK506 immunosuppression by conversion to cyclosporine in liver transplant recipients. |
1994 |
Transplantation |
pmid:7513098
|